Role of type 2 immunity in intestinal inflammation
- PMID: 26376478
- PMCID: PMC4668267
- DOI: 10.1097/MOG.0000000000000212
Role of type 2 immunity in intestinal inflammation
Abstract
Purpose of review: Type 2 (Th2) immune responses play important roles in intestinal immunity by contributing to the maintenance of mucosal homeostasis, not only conferring protection against helminthic infection but also participating in pro-inflammatory pathways in chronic intestinal inflammatory disorders, including inflammatory bowel disease. The current review focuses on recent developments regarding the role of Th2 responses in intestinal inflammation.
Recent findings: Th2 gut mucosal responses are promoted by mediators that are released following injury to the epithelium, and act as alarmin-type danger signals. Interleukin (IL)-33 is prominent among such factors and demonstrates a dichotomous function, exerting either protective or pro-inflammatory effects, depending on its cellular compartmentalization. The pool of type 2 effector cells has been enriched recently to include not only classical CD4+ Th2 lymphocytes but also a subset of innate lymphocytes (ILC2s) that express the transcriptional factor GATA binding protein 3 and secrete IL-4, IL-5, and IL-13. ILC2s play important roles during infection with helminths and bi-directionally interact with Th2 CD4+ lymphocytes, thus establishing a transition from innate to adaptive immunological pathways. Th2 responses are also involved in pro-inflammatory pathways at the intestinal mucosa, and neutralization of the pivotal cytokines IL-4 and IL-13 has been shown to regulate experimental intestinal inflammation. In striking contrast, however, neutralization of human IL-13 had no therapeutic effect in patients with ulcerative colitis.
Summary: Further studies will be required to delineate the specific mechanisms of type 2 mucosal immunity in inflammatory bowel disease and examine the applicability of Th2-targeted therapies for intestinal inflammation.
Conflict of interest statement
Conflicts of interest: None.
Similar articles
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.Front Immunol. 2019 Mar 27;10:583. doi: 10.3389/fimmu.2019.00583. eCollection 2019. Front Immunol. 2019. PMID: 30972074 Free PMC article. Review.
-
IL-33 and the intestine: The good, the bad, and the inflammatory.Cytokine. 2017 Dec;100:1-10. doi: 10.1016/j.cyto.2017.06.017. Epub 2017 Jul 4. Cytokine. 2017. PMID: 28687373 Free PMC article. Review.
-
Cytokines and mucosal immunity.Curr Opin Gastroenterol. 2014 Nov;30(6):547-52. doi: 10.1097/MOG.0000000000000118. Curr Opin Gastroenterol. 2014. PMID: 25203451 Free PMC article. Review.
-
Cytokines and intestinal inflammation.Curr Opin Gastroenterol. 2016 Nov;32(6):437-442. doi: 10.1097/MOG.0000000000000315. Curr Opin Gastroenterol. 2016. PMID: 27673380 Review.
Cited by
-
ILC2 Proliferated by IL-33 Stimulation Alleviates Acute Colitis in Rag1-/- Mouse through Promoting M2 Macrophage Polarization.J Immunol Res. 2020 Jun 25;2020:5018975. doi: 10.1155/2020/5018975. eCollection 2020. J Immunol Res. 2020. PMID: 32676507 Free PMC article.
-
Immune response modulation in inflammatory bowel diseases by Helicobacter pylori infection.World J Gastroenterol. 2023 Aug 14;29(30):4604-4615. doi: 10.3748/wjg.v29.i30.4604. World J Gastroenterol. 2023. PMID: 37662864 Free PMC article. Review.
-
The role of oral bacteria in inflammatory bowel disease.Nat Rev Gastroenterol Hepatol. 2021 Oct;18(10):731-742. doi: 10.1038/s41575-021-00488-4. Epub 2021 Aug 16. Nat Rev Gastroenterol Hepatol. 2021. PMID: 34400822 Review.
-
Milk-derived extracellular vesicles protect intestinal barrier integrity in the gut-liver axis.Sci Adv. 2023 Apr 14;9(15):eade5041. doi: 10.1126/sciadv.ade5041. Epub 2023 Apr 12. Sci Adv. 2023. PMID: 37043568 Free PMC article.
-
Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection.Int J Mol Sci. 2019 Apr 18;20(8):1912. doi: 10.3390/ijms20081912. Int J Mol Sci. 2019. PMID: 31003422 Free PMC article. Review.
References
-
- Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2015;135:626–635. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials